CY1107745T1 - Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια - Google Patents
Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουριαInfo
- Publication number
- CY1107745T1 CY1107745T1 CY20071101241T CY071101241T CY1107745T1 CY 1107745 T1 CY1107745 T1 CY 1107745T1 CY 20071101241 T CY20071101241 T CY 20071101241T CY 071101241 T CY071101241 T CY 071101241T CY 1107745 T1 CY1107745 T1 CY 1107745T1
- Authority
- CY
- Cyprus
- Prior art keywords
- diabetes
- thiazolidinodion
- sulfonyluria
- treatment
- secretin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Μέθοδος για την αγωγή του σακχαροδιαβήτη και καταστάσεων σχετιζόμενων με το σακχαροδιαβήτη σε ένα θηλαστικό, η οποία μέθοδος περιλαμβάνει τη χορήγηση μίας αποτελεσματικής μη τοξικής φαρμακευτικά αποδεκτής ποσότητος ενός ευαισθητοποιητή της ινσουλίνης και μίας μικρότερης από τη μέγιστη ποσότητας ενός εκκριταγωγού της ινσουλίνης, σε ένα θηλαστικό το οποίο την έχει ανάγκη και μία φαρμακευτική σύνθεση για χρήση σε μία τέτοια μέθοδο.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715306A GB9715306D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
EP98935126A EP0998291B2 (en) | 1997-07-18 | 1998-07-16 | Treatment of diabetes with thiazolidinedione and sulphonylurea |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107745T1 true CY1107745T1 (el) | 2013-04-18 |
Family
ID=10816177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071101241T CY1107745T1 (el) | 1997-07-18 | 2007-09-27 | Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια |
Country Status (41)
Country | Link |
---|---|
EP (1) | EP0998291B2 (el) |
JP (2) | JP2001510158A (el) |
KR (1) | KR100680667B1 (el) |
CN (1) | CN1264302A (el) |
AP (1) | AP1318A (el) |
AR (2) | AR016768A1 (el) |
AT (1) | ATE366577T1 (el) |
AU (1) | AU743269B2 (el) |
BG (1) | BG64892B1 (el) |
BR (1) | BR9810904A (el) |
CA (1) | CA2297115C (el) |
CO (1) | CO4940422A1 (el) |
CY (1) | CY1107745T1 (el) |
CZ (1) | CZ302668B6 (el) |
DE (1) | DE69838066T3 (el) |
DK (1) | DK0998291T4 (el) |
DZ (1) | DZ2564A1 (el) |
EA (1) | EA003303B1 (el) |
ES (1) | ES2290989T5 (el) |
GB (1) | GB9715306D0 (el) |
HK (1) | HK1029272A1 (el) |
HU (1) | HU229119B1 (el) |
ID (1) | ID24198A (el) |
IL (1) | IL134045A0 (el) |
IN (1) | IN189035B (el) |
MA (1) | MA26522A1 (el) |
MY (1) | MY138246A (el) |
NO (1) | NO326356B1 (el) |
NZ (3) | NZ520652A (el) |
OA (1) | OA11632A (el) |
PE (1) | PE99799A1 (el) |
PL (2) | PL199125B1 (el) |
PT (1) | PT998291E (el) |
SI (1) | SI0998291T2 (el) |
SK (2) | SK287823B6 (el) |
TR (1) | TR200000135T2 (el) |
TW (1) | TW586926B (el) |
UA (1) | UA70302C2 (el) |
UY (1) | UY25103A1 (el) |
WO (1) | WO1999003476A1 (el) |
ZA (1) | ZA986365B (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1832291A3 (en) * | 1999-07-13 | 2009-11-04 | Medicure Inc. | use of pyridoxal phosphate for the treatment of diabetes and related complications |
EP1897547A1 (en) * | 1999-07-13 | 2008-03-12 | Medicure Inc. | Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications |
US6586438B2 (en) | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
US20010036479A1 (en) | 2000-01-14 | 2001-11-01 | Gillian Cave | Glyburide composition |
MXPA03006217A (es) | 2001-01-12 | 2004-10-15 | Sun Pharmaceutical Ind Ltd | Sistema de administracion espaciada de farmacos. |
US7700128B2 (en) * | 2003-10-31 | 2010-04-20 | Takeda Pharmaceutical Company Limited | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
JP2008019169A (ja) * | 2004-10-25 | 2008-01-31 | Osaka Univ | 新規ppar調節剤およびそのスクリーニング方法 |
EP1962811B1 (en) | 2005-12-22 | 2016-04-27 | Takeda Pharmaceutical Company Limited | Solid preparation containing an insulin sensitizer |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS5697277A (en) * | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
US4582839A (en) * | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
US4812570A (en) * | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group Plc | Substituierte Thiazolidindionderivate |
US4791125A (en) * | 1987-12-02 | 1988-12-13 | Pfizer Inc. | Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents |
WO1989008651A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
WO1989008650A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
JPH04210683A (ja) * | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
US5183823A (en) * | 1991-04-11 | 1993-02-02 | Takeda Chemical Industries, Ltd. | Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents |
EP0528764B1 (en) * | 1991-08-16 | 1996-06-12 | Sandoz Ltd. | Inhaler for administration of powdery substances |
ES2101866T3 (es) * | 1991-08-26 | 1997-07-16 | Upjohn Co | Producto alimentario liquido que contiene acido 3-guanidinopropionico. |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
-
1997
- 1997-07-18 GB GB9715306A patent/GB9715306D0/en active Pending
-
1998
- 1998-07-15 DZ DZ980174A patent/DZ2564A1/xx active
- 1998-07-16 SK SK60-2000A patent/SK287823B6/sk not_active IP Right Cessation
- 1998-07-16 NZ NZ520652A patent/NZ520652A/en not_active IP Right Cessation
- 1998-07-16 AP APAP/P/2000/001734A patent/AP1318A/en active
- 1998-07-16 MA MA25173A patent/MA26522A1/fr unknown
- 1998-07-16 BR BR9810904-9A patent/BR9810904A/pt not_active Application Discontinuation
- 1998-07-16 NZ NZ515555A patent/NZ515555A/xx not_active IP Right Cessation
- 1998-07-16 TR TR2000/00135T patent/TR200000135T2/xx unknown
- 1998-07-16 PT PT98935126T patent/PT998291E/pt unknown
- 1998-07-16 DE DE69838066T patent/DE69838066T3/de not_active Expired - Lifetime
- 1998-07-16 JP JP2000502775A patent/JP2001510158A/ja not_active Withdrawn
- 1998-07-16 CZ CZ20000173A patent/CZ302668B6/cs not_active IP Right Cessation
- 1998-07-16 EP EP98935126A patent/EP0998291B2/en not_active Expired - Lifetime
- 1998-07-16 IL IL13404598A patent/IL134045A0/xx unknown
- 1998-07-16 HU HU0003634A patent/HU229119B1/hu unknown
- 1998-07-16 CN CN98807221A patent/CN1264302A/zh active Pending
- 1998-07-16 SI SI9830892T patent/SI0998291T2/sl unknown
- 1998-07-16 AT AT98935126T patent/ATE366577T1/de active
- 1998-07-16 AU AU84487/98A patent/AU743269B2/en not_active Expired
- 1998-07-16 EA EA200000141A patent/EA003303B1/ru not_active IP Right Cessation
- 1998-07-16 SK SK89-2005A patent/SK288053B6/sk not_active IP Right Cessation
- 1998-07-16 DK DK98935126.7T patent/DK0998291T4/da active
- 1998-07-16 ID IDW20000074A patent/ID24198A/id unknown
- 1998-07-16 UA UA2000010215A patent/UA70302C2/uk unknown
- 1998-07-16 ES ES98935126T patent/ES2290989T5/es not_active Expired - Lifetime
- 1998-07-16 PL PL375989A patent/PL199125B1/pl unknown
- 1998-07-16 PE PE1998000631A patent/PE99799A1/es not_active Application Discontinuation
- 1998-07-16 OA OA1200000014A patent/OA11632A/en unknown
- 1998-07-16 NZ NZ501256A patent/NZ501256A/xx not_active IP Right Cessation
- 1998-07-16 PL PL98338127A patent/PL338127A1/xx not_active Application Discontinuation
- 1998-07-16 WO PCT/GB1998/002109 patent/WO1999003476A1/en active IP Right Grant
- 1998-07-16 KR KR1020007000513A patent/KR100680667B1/ko not_active IP Right Cessation
- 1998-07-16 CA CA2297115A patent/CA2297115C/en not_active Expired - Lifetime
- 1998-07-17 CO CO98040748A patent/CO4940422A1/es unknown
- 1998-07-17 MY MYPI98003290A patent/MY138246A/en unknown
- 1998-07-17 AR ARP980103516A patent/AR016768A1/es not_active Application Discontinuation
- 1998-07-17 ZA ZA9806365A patent/ZA986365B/xx unknown
- 1998-07-17 TW TW087111768A patent/TW586926B/zh not_active IP Right Cessation
- 1998-07-17 UY UY25103A patent/UY25103A1/es not_active IP Right Cessation
- 1998-07-20 IN IN2089DE1998 patent/IN189035B/en unknown
-
1999
- 1999-06-18 AR ARP990102953A patent/AR019331A2/es unknown
-
2000
- 2000-01-17 NO NO20000229A patent/NO326356B1/no not_active IP Right Cessation
- 2000-02-08 BG BG104139A patent/BG64892B1/bg active Active
- 2000-10-24 HK HK00106765A patent/HK1029272A1/xx not_active IP Right Cessation
-
2005
- 2005-04-21 JP JP2005123586A patent/JP2005247865A/ja active Pending
-
2007
- 2007-09-27 CY CY20071101241T patent/CY1107745T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107745T1 (el) | Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια | |
CY1107643T1 (el) | Αντιμετωπιση του διαβητη με θειαζολιδινοδιονη και μετφορμινη | |
CY1105254T1 (el) | Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο | |
CY1119109T1 (el) | Συσκευη που μπορει να εμφυτευθει που περιεχει υλικο μητρας που μπορει να απορροφηθει και ραπαμυκινη για την προληψη ή την θεραπεια αγγειο-πολλαπλασιαστικων ασθενειων | |
NO976063L (no) | Fremgangsmåte for behandling av diabetes | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
ES2059121T5 (es) | Uso de agentes sensibilizantes de la insulina para tratar la hipertension. | |
TR200101174T2 (tr) | Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid. | |
DE69811105D1 (de) | Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod | |
IT1279684B1 (it) | Siringa per iniezioni ipodermiche. | |
AR019724A2 (es) | Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas | |
AR008025A1 (es) | Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina | |
CY1106892T1 (el) | Νεα μεθοδος θεραπειας | |
NO996270L (no) | Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor | |
DK1156795T3 (da) | Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens | |
CO5170459A1 (es) | Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos | |
CY1105657T1 (el) | Θεραπεια ηπατιτιδας c με θυμοσινη και σταθεροποιημενη ιντερφερονη | |
TR200000957T2 (tr) | Hiperglisemi tedavisinde tiazolidinedion kullanımı | |
EA200000419A1 (ru) | Применение тиазолидиндионов для лечения гипергликемии | |
ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
EA200300222A1 (ru) | Лечение гепатита c с помощью тимозина, интерферона и рибавирина | |
ECSP982542A (es) | Nuevo metodo de tratamiento iii | |
EA199800820A1 (ru) | Способ лечения злоупотребления лекарственными средствами | |
ECSP982592A (es) | Nuevo metodo de tratamiento v | |
ECSP993003A (es) | Uso de peg - ifn -alpha y ribavirina para el tratamiento de hepatitis c cronica |